News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Delcath Systems, Inc. (DCTH) Gets FDA Nod to Resume Enrollment in Trials



11/21/2007 6:59:12 AM

Nov 20 (Reuters) - Drug delivery systems maker Delcath Systems Inc (DCTH.O: Quote, Profile, Research) said U.S. health regulators allowed the company to resume patient enrollment in the late- and mid-stage trials of its system used in the treatment of certain liver cancers, sending shares up 47 percent.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES